Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Verrica Pharmaceuticals Inc
(NQ:
VRCA
)
2.820
+0.030 (+1.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Verrica Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
Next >
50 Stocks Moving In Wednesday's Mid-Day Session
May 25, 2022
Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) gained 178.3% to $0.3762 as the company announced it increased retail distribution across Canada with Loblaw Companies.
Via
Benzinga
Mid-Morning Market Update: Markets Rise; Nasdaq Gains 100 Points
May 25, 2022
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 100 points on Wednesday.
Via
Benzinga
Express (EXPR) Stock Pops 9% After Better-Than-Expected Q1 Earnings
May 25, 2022
Express (EXPR) stock is rising higher on Wednesday after the fashion retailer reported results for the first quarter of 2022.
Via
InvestorPlace
Why Is Verrica Pharmaceuticals (VRCA) Stock Plunging 55% Today?
May 25, 2022
VRCA stock is sinking over 50% in morning trading after the FDA declined to approve the company's treatment for "a viral skin disease."
Via
InvestorPlace
Why Verrica Pharma Shares Are Plunging Today
May 25, 2022
Via
Benzinga
Recap: Verrica Pharmaceuticals Q1 Earnings
May 09, 2022
Verrica Pharmaceuticals (NASDAQ:VRCA) reported its Q1 earnings results on Monday, May 9, 2022 at 07:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022
May 25, 2022
Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of...
Via
Benzinga
Why Is Dick’s Sporting Goods (DKS) Stock Down 6% Today?
May 25, 2022
Dick's Sporting Goods (DKS) stock is taking a beating on Wednesday after the retailer released its earnings report for Q1 2022.
Via
InvestorPlace
The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine
May 25, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 26, 2022
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
January 18, 2022
Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 25, 2022
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
May 25, 2022
Telsey Advisory Group cut Ralph Lauren Corporation (NYSE: RL) price target from $160 to $140. Ralph Lauren shares fell 3% to $88.40 in pre-market trading.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 25, 2022
Rise and shine, traders! We're starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
21 Stocks Moving in Wednesday's Pre-Market Session
May 25, 2022
Gainers The Singing Machine Company, Inc. (NASDAQ: MICS) shares rose 47.3% to $4.05 in pre-market trading.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 24, 2022
Gainers
Via
Benzinga
The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures
May 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
'Pharma Bro' Martin Shkreli Says He Toyed With Crypto On Uniswap — Vitalik Buterin Reacts
May 22, 2022
Martin Shkreli, who infamously raised the price of an antiparasitic drug by 5,455% in 2017, sang praises of Ethereum (CRYPTO: ETH)-based decentralized cryptocurrency exchange Uniswap (UNI) after...
Via
Benzinga
The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More
May 22, 2022
Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.
Via
Benzinga
7 Biotech Stocks With Key Catalysts for May
May 11, 2022
The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns.
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
May 04, 2022
During Wednesday's trading, 435 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
May 03, 2022
Tuesday's session saw 211 companies set new 52-week lows.
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
May 01, 2022
The month of April was a mixed one for regulatory approvals. The Food and Drug Administration delayed approvals for at least three treatment candidates. New molecular entity, or NME, approvals, a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2022
March 10, 2022
Upgrades For Alpha Metallurgical Resources Inc (NYSE:AMR), B. Riley Securities upgraded the previous rating of Neutral to Buy. For the fourth quarter, Alpha Metallurgical...
Via
Benzinga
The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street
December 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Calliditas Gets Conditional Approval For Kidney Inflammation Disease Drug...
Via
Benzinga
FDA Accepts Verrica's Resubmission For VP-102 For Contagious Skin Disease
December 16, 2021
The FDA has accepted Verrica Pharmaceuticals Inc's (NASDAQ: VRCA) resubmitted marketing application seeking approval for VP-102 to treat molluscum contagiosum (...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 15, 2021
Gainers Calliditas Therapeutics (NASDAQ:
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
October 01, 2021
Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned. Four new...
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
September 22, 2021
Piper Sandler boosted the price target for Adobe Inc. (NASDAQ: ADBE) from $600 to $670. Adobe shares fell 3.5% to $623.50 in pre-market trading. Keybanc reduced the price target...
Via
Benzinga
50 Biggest Movers From Yesterday
September 22, 2021
Check out these big penny stock gainers and losers Losers Edesa Biotech, Inc. (NASDAQ: EDSA) shares dipped 29.9% to close at $8.36 on profit-taking after the stock...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.